Table 2 Demographic table.
Discovery Cohort | Evaluation Cohort | |||||
|---|---|---|---|---|---|---|
Healthy donors (n = 16) | Parkinson’s disease (n = 16) | p value | Healthy donors (n = 15) | Parkinson’s disease (n = 30) | p value | |
Age, mean (SD) | 59.5 (6.35) | 73.7 (2.89) | 0.004 | 60.3 (5.6) | 64.2 (6.7) | 0.065 |
Sex, Male, n (%) | 9 (56.3%) | 8 (50%) | 0.727 | 9 (60.0%) | 15 (50%) | 0.531 |
BMI, mean (SD) | NA | 25.2 (3.7) | NA | 26.1 (3.2) | ||
Caucasian, n (%) | 16 (100%) | 16 (100%) | 1.000 | 15 (100%) | 30 (100%) | 1.000 |
Years since diagnosis, mean (SD) | NA | 1.5 (2.0) | NA | 1.1 (0.4) | ||
Signs Hypokinesia, n (%) Postural instability, n (%) Muscle rigidity, n (%) Tremor, n (%) | 5 (31.3%) 9 (56.3%) 6 (37.5%) 9 (56.3%) | 8 (26.7%) 10 (33.3%) 14 (46.7%) 16 (53.3%) | ||||
Current treatment Levodopa, n (%) | 8 (50%) | 10 (33.3%) | ||||
